Phase I clinical trial in patients with advanced (stage III or IV) melanoma

The study protocol that will be used for this trial has been reviewed by the local ethical committee and is now ready to be submitted to Läkemedelsverket, the Swedish regulatory authority for clinical trials.

Upon approval by Swedish authorities we plan to include, treat and evaluate 10 patients during a period of one to two years. It will probably start in 2009 and data will become available.

created over 14 years ago (16 December 2009)    last modified over 11 years ago (4 January 2013)   [ RDF ]   [ RelFinder ]